跳至主要内容
临床试验/IRCT20221130056672N6
IRCT20221130056672N6尚未招募1 期

Assessment of Safety and Efficacy of Intradermal Injection of Wharton's jelly Mesenchymal Cells Derived Extracellular Vesicles With CO2 Laser in Treatment of Melasma(A randomized controlled intervention study)

Tehran University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 50 years(—)
性别
Female

入选标准

  • Age between 18 and 50 years Full satisfaction of the participant in the plan Has melasma (with all three degrees of mild, moderate, severe)

排除标准

  • Previous treatment of melasma
  • Pregnancy and Breastfeeding
  • Active skin infection
  • Use of drugs that can affect bleeding or clotting mechanism
  • Immunosuppression
  • Use of local and systemic steroids Disease systemic diseases (such as high blood pressure ,Diabetes ,heart, kidney and liver diseases)
  • The use of exfoliators 4 weeks before treatment In places where botulinum injection has been done, should not be done due to the possibility of microneedle toxin release.
  • Participation in other clinical trials

研究者

相似试验